We are live on ! Find out more

Renaissance IPO ETF

IPO

Market cap $142M

50.62 USD

+1.09

2.2%

At close Updated Oct 28, 4:00 PM EDT

1 day

2.2%

5 days

3.16%

1 month

-3.67%

3 months

-1.5%

6 months

6.46%

Year to date

7.66%

1 year

2.82%

5 years

-25.96%

10 years

149.98%

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 50%

Neutral 25%

Negative 25%

Proactive Investors

IP Group invests £4m as Microbiotica raises £36m for clinical trials

IP Group PLC (LSE:IPO) has invested £4 million in a £36 million funding round for portfolio company Microbiotica, backing the development of a potential new treatment for ulcerative colitis. The Series C financing, led by British Business Bank, will support the progression of Microbiotica's lead drug candidate, MB310, into Phase 2 clinical trials following encouraging early-stage results.

IP Group invests £4m as Microbiotica raises £36m for clinical trials

Zacks Investment Research

3 Reasons Why Anthropic IPO Could Be Huge: ETFs in Focus

Anthropic is heading toward a potential blockbuster IPO, fueled by rapid revenue growth, major AI deals and ambitious valuation targets.

3 Reasons Why Anthropic IPO Could Be Huge: ETFs in Focus

CNBC Television

Barclays' Kristin Peterson on the retail appetite for tech IPOs

Kristin Peterson, Barclays Technology Investment Banking global head, joins 'Squawk on the Street' to discuss the retail appetite for tech IPOs.

Barclays' Kristin Peterson on the retail appetite for tech IPOs

24/7 Wall Street

SpaceX Raised $86 Billion and OpenAI Is Next. This ETF Owns the IPO Class of 2026

The 2026 IPO window blew open this summer. SpaceX's June listing pulled in a reported $86 billion according to Benzinga and other outlets, and Anthropic is now being floated as the next challenger to that record, with OpenAI chatter never far behind.

SpaceX Raised $86 Billion and OpenAI Is Next. This ETF Owns the IPO Class of 2026

Zacks Investment Research

U.S. IPO Market Has More Room to Rally in H2 2026: ETFs Poised to Win

The next phase of the IPO rally could extend beyond tech mega-deals, driven by a more diversified pipeline, benefiting ETFs like FPX and IPO.

U.S. IPO Market Has More Room to Rally in H2 2026: ETFs Poised to Win

Zacks Investment Research

ETFs in Focus as Anthropic Eyes a Blockbuster IPO

Anthropic's potential IPO could be a blockbuster. Here's how AI and IPO-focused ETFs may benefit from one of the biggest listings in tech.

ETFs in Focus as Anthropic Eyes a Blockbuster IPO

Zacks Investment Research

SpaceX IPO Set to Be a Catalyst for 2026 IPO Boom: ETFs to Gain

SpaceX could be the catalyst for a surge as the U.S. IPO market eyes a comeback. ETFs like FPX, IPO and IPOS offer an easy way to gain exposure.

SpaceX IPO Set to Be a Catalyst for 2026 IPO Boom: ETFs to Gain

U.S. IPO Weekly Recap: REIT Carve-Out Sees Solid Demand While Drone Micro-Cap Soars 500%+

Three IPOs priced this past week, joined by two SPACs, and one major issuer joined the pipeline. One IPO and one direct listing are currently scheduled in the week ahead, although some smaller issuers may join the calendar throughout the week. Street research is expected for one company in the week ahead, and three lock-up periods will be expiring.

U.S. IPO Weekly Recap: REIT Carve-Out Sees Solid Demand While Drone Micro-Cap Soars 500%+

AMG TimesSquare Small Cap Growth Fund Q4 2025 Performance Insights

The Fund rebounded and outperformed the Russell 2000 ® Growth Index in the fourth quarter. Boot Barn's revenues and earnings handily exceeded estimates, with greater transaction volumes and new store openings. Abivax reported strong clinical trial results for its obefazimod treatment to address ulcerative colitis in a longer lasting manner.

AMG TimesSquare Small Cap Growth Fund Q4 2025 Performance Insights

AI-Induced Tech Selloff Spoils the IPO Parade

This year was supposed to be a blockbuster for tech offerings of all sizes.

AI-Induced Tech Selloff Spoils the IPO Parade

See News Rankings

Price charts implemented using Lightweight Charts™